tirzepatide with b3 Hush Medical Spa Join the thousands of people who have already achieved their weight loss goals through this program. Compounded Tirzepatide with B3 |

TRIUMPH-CVOT, the cardiovascular outcomes trial in roughly 10,000 patients with established cardiovascular disease, is not expected to report until 2028 or 2029, but interim safety reviews matter

A study of nearly 13,000 people with diabetes and asthma found that metformin cut a patient's odds for asthma attacks by 30%, while adding in a GLP-1 med reduced it by another 40%

The authors analyzed differentially expressed genes and, upon further experimentation, involving HepG2 cells induced with palmitic acid, demonstrated that tirzepatide alleviates intrahepatic lipid accumulation in MASLD by downregulating CD36 and OBP2A, the key proteins involved in fatty acid uptake

The Chronobiologic-Based Practical Approach to Shift Work

A provider decides whether a compounded option is clinically appropriate

This section summarizes the most influential clinical trials in immunotherapy and cell/gene-based approaches for type 1 diabetes (T1D), with particular emphasis on their reported efficacy and the remaining feasibility challenges